ISEQ surges ahead
The ISEQ rose 77.55 points to 7596.29 today as the main players posted gains.
Elan rose 30c to €12.20 today following news that it has agreed to sell the rights to its Prialt drug for the treatment of chronic pain in Europe to Eisai, while retaining the product rights in the United States.





